<DOC>
	<DOCNO>NCT00257556</DOCNO>
	<brief_summary>Prospective open label , randomise , parallel group , comparative pilot .</brief_summary>
	<brief_title>A Study Efficacy Safety Highly Purified Menotrophin Versus Recombinant Follitropin Alfa</brief_title>
	<detailed_description>Ongoing pregnancy rate , define positive fetal heart action 9 week first positive pregnancy test . Number/diameter follicle , number oocyte retrieve , number pronuclear oocyte ( refer zygotes pre-embryos UK ) , quality pronuclear stage oocyte , number embryo transfer , quality embryo , number frozen embryo , endometrial thickness morphology day HCG administration , estradiol level day HCG administration , implantation rate , number day stimulate gonadotrophin number ampoule use , clinical pregnancy rate 6 week first positive pregnancy test , pregnancy outcome .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Female patient age &gt; = 20 &lt; = 35 year BMI &gt; 18 &lt; 32 kg/m2 receive two previous cycle vitro fertilisation ( IVF ) assist reproductive technique ( ART ) whose partner normal sperm ( accord WHO 1999 criterion ) . Inclusion criterion : Signed informed consent ; Subfertile premenopausal female patient eligible IVF treatment ; Aged &gt; =20 &lt; =35 year ; Body mass index &gt; 18 &lt; 32 kg/m2 Normal endocrine assessment within last 6 month ; Normal pelvic ultrasound ( show two ovary , ovarian abnormality normal uterus ) within last 6 month ; Receipt two previous cycle IVF ( ART ) ; At least 3 consecutive ovulatory menstrual cycle 2435 day , document evidence ovulatory cycle within previous 12 month ; No fertilitymodifying treatment within 3 month prior treatment cycle ; Infertility attributable association either tubal factor , unexplained cause ; Sperm partner class normal accord WHO 1999 criterion within year prior begin therapy ; Negative serum betaHCG pregnancy test prior begin therapy ; Clinically normal baseline haematology , clinical chemistry , urinalysis parameter value , negative serum HBsAg HIV antibody test ; Screening endocrine test result ( estradiol , LH , FSH , progesterone , prolactin , TSH ) early follicular phase within normal limit clinical laboratory . Exclusion criterion Presence clinically relevant systemic disease ( e.g . insulin dependent diabetes mellitus ) ; A history current endocrine disease , include polycystic ovary like syndrome hyperprolactinaemia ; A history coagulation disorder ; Persistent ovarian cyst ; Contraindications use gonadotrophin GnRH antagonists ; A history hypersensitivity constituent study medication related compound ; Three previous cycle IVF ( ART ) ; A history alcohol abuse ( 30 unit per week regular basis ) ; History chemo radiotherapy ; Currently breastfeed , pregnant contraindication pregnancy ; Diagnosed poor responder prior IVF treatment ; History severe ovarian hyperstimulation syndrome ( OHSS ) ( 4 5 ) former IVF treatment ; Investigational drug within 30 day prior treatment ; Any condition history investigator considers might increase risk individual .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>